Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
1.560
0.00 (-0.01%)
Apr 29, 2026, 1:05 PM EDT - Market open
Adial Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 5.88 | 3.75 | 2.83 | 4 | 6.06 | Upgrade
|
| Cash & Short-Term Investments | 5.88 | 3.75 | 2.83 | 4 | 6.06 | Upgrade
|
| Cash Growth | 56.81% | 32.66% | -29.35% | -33.99% | 37.74% | Upgrade
|
| Prepaid Expenses | 0.3 | 0.31 | 0.37 | 0.35 | 0.39 | Upgrade
|
| Other Current Assets | - | - | - | 0.43 | 0.01 | Upgrade
|
| Total Current Assets | 6.18 | 4.06 | 3.2 | 4.78 | 6.46 | Upgrade
|
| Property, Plant & Equipment | - | - | - | - | 0.3 | Upgrade
|
| Long-Term Investments | 0.49 | 0.98 | 1.53 | - | - | Upgrade
|
| Goodwill | - | - | - | - | 0.25 | Upgrade
|
| Other Intangible Assets | 0 | 0 | 0 | 0 | 0.46 | Upgrade
|
| Other Long-Term Assets | - | - | - | 0.95 | - | Upgrade
|
| Total Assets | 6.67 | 5.04 | 4.74 | 5.73 | 7.47 | Upgrade
|
| Accounts Payable | 0.66 | 0.3 | 0.13 | 0.28 | 0.29 | Upgrade
|
| Accrued Expenses | 0.74 | 0.68 | 0.53 | 1.14 | 2.38 | Upgrade
|
| Current Portion of Leases | - | - | - | - | 0.05 | Upgrade
|
| Other Current Liabilities | - | - | - | 0.38 | 0.01 | Upgrade
|
| Total Current Liabilities | 1.4 | 0.98 | 0.65 | 1.79 | 2.72 | Upgrade
|
| Long-Term Leases | - | - | - | - | 0.21 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | - | - | 0.02 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | 0.67 | 1.01 | Upgrade
|
| Total Liabilities | 1.4 | 0.98 | 0.65 | 2.46 | 3.97 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0.02 | Upgrade
|
| Additional Paid-In Capital | 95.25 | 86.06 | 72.88 | 66.95 | 54.43 | Upgrade
|
| Retained Earnings | -89.97 | -82 | -68.8 | -63.67 | -50.94 | Upgrade
|
| Shareholders' Equity | 5.28 | 4.07 | 4.08 | 3.28 | 3.51 | Upgrade
|
| Total Liabilities & Equity | 6.67 | 5.04 | 4.74 | 5.73 | 7.47 | Upgrade
|
| Total Debt | - | - | - | - | 0.26 | Upgrade
|
| Net Cash (Debt) | 5.88 | 3.75 | 2.83 | 4 | 5.81 | Upgrade
|
| Net Cash Growth | 56.81% | 32.66% | -29.35% | -31.07% | 31.90% | Upgrade
|
| Net Cash Per Share | 8.80 | 19.33 | 49.61 | 99.90 | 195.19 | Upgrade
|
| Filing Date Shares Outstanding | 1.43 | 0.26 | 0.16 | 0.05 | 0.04 | Upgrade
|
| Total Common Shares Outstanding | 1.11 | 0.26 | 0.07 | 0.04 | 0.03 | Upgrade
|
| Working Capital | 4.78 | 3.08 | 2.55 | 2.99 | 3.74 | Upgrade
|
| Book Value Per Share | 4.75 | 15.71 | 61.37 | 76.73 | 104.66 | Upgrade
|
| Tangible Book Value | 5.27 | 4.06 | 4.08 | 3.27 | 2.8 | Upgrade
|
| Tangible Book Value Per Share | 4.75 | 15.69 | 61.31 | 76.63 | 83.51 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.